NOVADIGM THERAPEUTICS
NovaDigm Therapeutics develops vaccines to protect patients from fungal and bacterial infections. Its products include NDV-3, a vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by fungal and bacterial pathogens; and Als3, an antigen vaccine, which provides protection against systemic and mucosal candidal infections. It was founded in 2005 and headquartered in Grand Forks, North Dakota.
NOVADIGM THERAPEUTICS
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2005-01-01
Address:
Grand Forks, North Dakota, United States
Country:
United States
Website Url:
http://www.novadigm.net
Total Employee:
11+
Status:
Active
Contact:
7013357121
Email Addresses:
[email protected]
Total Funding:
64.82 M USD
Technology used in webpage:
Viewport Meta Google Analytics Mobile Non Scaleable Content AJAX Libraries API Pound Sterling Google Analytics Classic Japanese Yen
Current Advisors List
Current Employees Featured
Founder
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - NovaDigm Therapeutics
RMI Partners
RMI Partners investment in Convertible Note - NovaDigm Therapeutics
RMI Partners
RMI Partners investment in Series B - NovaDigm Therapeutics
Domain Associates
Domain Associates investment in Series B - NovaDigm Therapeutics
RMI Partners
RMI Partners investment in Series B - NovaDigm Therapeutics
Domain Associates
Domain Associates investment in Series A - NovaDigm Therapeutics
Official Site Inspections
http://www.novadigm.net Semrush global rank: 5.92 M Semrush visits lastest month: 1.39 K
- Host name: a67c48129651a0940.awsglobalaccelerator.com
- IP address: 13.248.213.45
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
